Health Care & Life Sciences » Biotechnology | PhoenixBio Co. Ltd.

PhoenixBio Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2015
2016
2017
2018
2019
Cash & Short Term Investments
668
1,604
1,635
933
657
Total Accounts Receivable
55
91
121
140
245
Inventories
161
181
144
192
173
Other Current Assets
41
13
27
78
60
Total Current Assets
926
1,888
1,927
1,343
1,135
Net Property, Plant & Equipment
435
438
447
450
470
Intangible Assets
2
3
5
367
288
Other Assets
8
9
7
9
8
Total Assets
1,370
2,337
2,385
2,169
1,905
ST Debt & Current Portion LT Debt
54
55
62
65
Accounts Payable
9
30
11
20
Income Tax Payable
5
25
7
6
Other Current Liabilities
66
109
61
130
Total Current Liabilities
135
219
142
221
Long-Term Debt
137
88
128
80
Provision for Risks & Charges
42
51
3
3
Other Liabilities
-
4
8
8
Total Liabilities
313
362
282
312
Common Equity (Total)
1,057
1,975
2,104
1,857
Total Shareholders' Equity
1,057
1,975
2,104
1,857
Total Equity
1,057
1,975
2,104
1,857
Liabilities & Shareholders' Equity
1,370
2,337
2,385
2,169

About PhoenixBio Co.

View Profile
Address
3-4-1 Kagamiyama
Higashi-Hiroshima Hiroshima 739
Japan
Employees -
Website http://www.phoenixbio.co.jp
Updated 07/08/2019
PhoenixBio Co., Ltd. operates as a holding company that develops technologies for mass propagation of human cells into laboratory animals. Its solutions encompass PXB mouse services, Tg & KO animal services, and hair regeneration projects. The firm also offers its technologies to researchers by conducting in-house study services with custom produced transgenic animals.